RPR107393 - A SQUALENE SYNTHASE INHIBITOR AND A POTENT CHOLESTEROL-LOWERING AGENT

被引:0
|
作者
AMIN, D [1 ]
NEEDLE, S [1 ]
RUTLEDGE, R [1 ]
GALCZENSKI, H [1 ]
BUSH, R [1 ]
HELE, D [1 ]
MAGUIRE, M [1 ]
NEUENSCHWANDER, K [1 ]
SPADA, A [1 ]
BILDER, G [1 ]
ROACH, A [1 ]
PERRONE, M [1 ]
机构
[1] RHONE POULENC RORER,COLLEGEVILLE,PA 19426
来源
FASEB JOURNAL | 1995年 / 9卷 / 04期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:A766 / A766
页数:1
相关论文
共 50 条
  • [1] RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: Comparison with inhibitors of HMG-CoA reductase
    Amin, D
    Rutledge, RZ
    Needle, SN
    Galczenski, HF
    Neuenschwander, K
    Scotese, AC
    Maguire, MP
    Bush, RC
    Hele, DJ
    Bilder, GE
    Perrone, MH
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 281 (02): : 746 - 752
  • [2] COMPARISON OF SQUALENE SYNTHASE INHIBITORY ACTIVITY OF 2 ENANTIOMERS OF RPR107393
    NEEDLE, S
    RUTLEDGE, R
    BUSH, R
    BILDER, G
    PERRONE, M
    AMIN, D
    FASEB JOURNAL, 1995, 9 (03): : A195 - A195
  • [3] RPR101821, a new potent cholesterol-lowering agent: Inhibition of squalene synthase and 7-dehydrocholesterol reductase
    Amin, D
    Rutledge, RZ
    Needle, SJ
    Hele, DJ
    Neuenswander, K
    Bush, RC
    Bilder, GE
    Perrone, MH
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 353 (02) : 233 - 240
  • [4] Squalene Synthase InhibitorsClinical Pharmacology and Cholesterol-Lowering Potential
    Valentine Charlton-Menys
    Paul N. Durrington
    Drugs, 2007, 67 : 11 - 16
  • [5] Squalene synthase inhibitors: Clinical pharmacology and cholesterol-lowering potential
    Charlton-Menys, Valentine
    Durrington, Paul N.
    DRUGS, 2007, 67 (01) : 11 - 16
  • [6] The squalene synthase inhibitor RPR 107393A reduces Aβ peptide level in an APP transgenic mouse model
    Pradier, L
    Canton, T
    Bouaiche, Z
    Benoit, P
    Benavides, J
    NEUROBIOLOGY OF AGING, 2004, 25 : S568 - S568
  • [7] Cholesterol-lowering agent
    不详
    GERIATRICS, 1997, 52 (08) : 22 - 22
  • [8] MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT
    ALBERTS, AW
    CHEN, J
    KURON, G
    HUNT, V
    HUFF, J
    HOFFMAN, C
    ROTHROCK, J
    LOPEZ, M
    JOSHUA, H
    HARRIS, E
    PATCHETT, A
    MONAGHAN, R
    CURRIE, S
    STAPLEY, E
    ALBERSSCHONBERG, G
    HENSENS, O
    HIRSHFIELD, J
    HOOGSTEEN, K
    LIESCH, J
    SPRINGER, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07): : 3957 - 3961
  • [9] Plasma cholesterol-lowering and transient liver dysfunction in mice lacking squalene synthase in the liver
    Nagashima, Shuichi
    Yagyu, Hiroaki
    Tozawa, Ryuichi
    Tazoe, Fumiko
    Takahashi, Manabu
    Kitamine, Tetsuya
    Yamamuro, Daisuke
    Sakai, Kent
    Sekiya, Motohiro
    Okazaki, Hiroaki
    Osuga, Jun-ichi
    Honda, Akira
    Ishibashi, Shun
    JOURNAL OF LIPID RESEARCH, 2015, 56 (05) : 998 - 1005
  • [10] A MECHANISM OF CHOLESTEROL-LOWERING EFFECT OF RPR101821(R) - INHIBITION OF SQUALENE SYNTHASE AND 7-DEHYDROCHOLESTEROL (7DHC) REDUCTASE
    RUTLEDGE, R
    NEEDLE, S
    GALCZENSKI, H
    BUSH, R
    HELE, D
    ROJAS, C
    ULLRICH, J
    NEUENSCHWANDER, K
    BILDER, G
    PERRONE, M
    AMIN, D
    FASEB JOURNAL, 1995, 9 (03): : A195 - A195